Pharmacokinetics and tissue distribution of Gentiopicroside following oral and intravenous administration in mice
Author(s)
Author(s)
Wang, C.-H.
Wang, Z.-T.
White, K. N.
Branford-White, C. J.
Date Issued
2004
Publisher
Springer
Journal
European Journal of Drug Metabolism and Pharmacokinetics
Volume
29
Issue
3
Start page
199
End page
203
Abstract
The pharmacokinetics and tissue distribution of Gentiopicroside (GPS), one of the major active components of the Gentiana species of medicinal plants, was studied following oral and intravenous administration in mice. The distribution of GPS in mice after oral and intravenous doses could be fitted to a two-compartments open model. The serum half-life of GPS was 6.1 h and 2.8 h for intravenous and oral administration, respectively.
The Tmax of GPS after oral administration was 0.50 h, and the bioavailability was 39.6%. The AUC following intravenous administration was kidney >serum >liver >spleen >lung >thymus >fat >heart >muscle >stomach ¡ntestinal gradient in individual tissues >brain. The MRT gradient was muscle >serum >lung >spleen >lung >intestinal>heart>stomach >brain >liver >thymus >kidney >fat. Overall the data show that GPS could be absorbed rapidly in mice, but with a low bioavailability, and could distribute to tissues extensively, but was generally cleared quickly with short MRTs. The study demonstrates the need for repeated dosage, or better, a slow release formulation as an ideal means of administering GPS.
The Tmax of GPS after oral administration was 0.50 h, and the bioavailability was 39.6%. The AUC following intravenous administration was kidney >serum >liver >spleen >lung >thymus >fat >heart >muscle >stomach ¡ntestinal gradient in individual tissues >brain. The MRT gradient was muscle >serum >lung >spleen >lung >intestinal>heart>stomach >brain >liver >thymus >kidney >fat. Overall the data show that GPS could be absorbed rapidly in mice, but with a low bioavailability, and could distribute to tissues extensively, but was generally cleared quickly with short MRTs. The study demonstrates the need for repeated dosage, or better, a slow release formulation as an ideal means of administering GPS.
SFU Affiliated Publication
No
Availability at SFU Library
No database links found.